HDL-C and HDL-C/ApoA-I Predict Long-Term Progression of Glycemia in Established Type 2 Diabetes | Zendy

Boris Waldman | Zendy; Alicia J. Jenkins | Zendy; Timothy M. E. Davis | Zendy; MarjaRiitta Taskinen | Zendy; Russell Scott | Zendy; Rachel O’Connell | Zendy; Val Gebski | Zendy; M. Ng | Zendy; Anthony Keech | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

HDL-C and HDL-C/ApoA-I Predict Long-Term Progression of Glycemia in Established Type 2 Diabetes

Author(s) -

Boris Waldman,

Alicia J. Jenkins,

Timothy M. E. Davis,

MarjaRiitta Taskinen,

Russell Scott,

Rachel O’Connell,

Val Gebski,

M. Ng,

Anthony Keech

Publication year - 2014

Publication title -

diabetes care

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 6.636

H-Index - 363

eISSN - 1935-5548

pISSN - 0149-5992

DOI - 10.2337/dc13-2738

Subject(s) - medicine , insulin resistance , endocrinology , type 2 diabetes , glycemic , fenofibrate , insulin , apolipoprotein b , diabetes mellitus , hazard ratio , cholesterol , confidence interval

Low HDL cholesterol (HDL-C) and small HDL particle size may directly promote hyperglycemia. We evaluated associations of HDL-C, apolipoprotein A-I (apoA-I), and HDL-C/apoA-I with insulin secretion, insulin resistance, HbA1c, and long-term glycemic deterioration, reflected by initiation of pharmacologic glucose control.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research